Supports independent initiatives addressing unmet medical needs in hemophilia, including research, quality improvement, or education. Projects must align with Pfizer's medical and scientific strategies. Applications undergo a competitive review by an expert panel, in partnership with the Hemostasis & Thrombosis Research Society.
Eligibility criteria are not specified for this grant opportunity.
